Analytical testing, QC

Thermo Fisher expands site, boosts biologics processing offering

28-Nov-2019 By Vassia Barba

Thermo Fisher Scientific doubles the capacity of its gene therapy and viral vector processing facility in Alachua, Florida, to provide scalability to customers.

GHO raises €975M for more European contract service buyouts

26-Nov-2019 By Nick Taylor

GHO Capital Partners raises €975m European healthcare fund to place another set of bets on contract service providers.

Fujifilm expands gene therapy analytical services with $55m lab

21-Nov-2019 By Vassia Barba

Fujifilm Diosynth opens a 60,000-square-feet Gene Therapy Innovation Center to support upstream, downstream and analytical development services.

CPhI Worldwide 2019

Early monitoring key to countering variability in bioproduction

14-Nov-2019 By Vassia Barba

Regardless of the quality of the raw materials used in bioproduction processes, variability is a very common threat that can be addressed, says Thermo Fisher executive.

Mesa Labs in $180m Gyros acquisition for biopharma asset development

12-Nov-2019 By Ben Hargreaves

Mesa Labs buys Gyros to gain access to the latter’s capabilities in the discovery, development and manufacture of biotherapeutics.

People on the Move: Outsourcing-Pharma roundup October ‘19

01-Nov-2019 By Melissa Fassbender

This month’s people on the move includes a new therapeutic lead at Advanced Clinical, with plans to create a network of investigation sites, as well as CEOs at AIT Bioscience and Pharm-Olam, who discuss plans for moving forward.

Eurofins to support San Diego-based incubator

31-Oct-2019 By Melissa Fassbender

Eurofins Discovery has signed a Founding Partner sponsorship agreement with BioLabs San Diego, a membership-based network of shared lab facilities.

HistoIndex expands AI-based digital pathology platform

31-Oct-2019 By Melissa Fassbender

The Singapore-based company recently expanded its AI-based digital pathology platform to support preclinical discovery and drug development programs.

GE Healthcare sets up UK biotech R&D lab

24-Oct-2019 By Vassia Barba

GE Healthcare opens lab space to provide developers with access to protein and cell analysis technologies to encourage networking and partnering on R&D services.

Bioanalytical CRO LGC adopts Quanterix’s automated analyzer for immunoassays

03-Oct-2019 By Vassia Barba

LGC announces the addition of Quanterix’s HD-X platform to its offering, enabling automated development and performing of immunoassays for ‘unprecedented insights’ into disease biology as well as drug efficacy and safety.

PPD expands bioanalytical lab, to hire 200

23-Sep-2019 By Melissa Fassbender

PPD is expanding its immunochemistry and biomarker space by 8,000 square feet, the addition of which will also support a dedicated team for one of the company’s global biopharmaceutical clients.

AI in drug development: ACRO, DIA, and Owkin to talk use cases and what comes next

18-Sep-2019 By Melissa Fassbender

There has been a lot of discussion surrounding the use of artificial intelligence in drug development – with several deals, alliances, and partnerships made so far this year. Here, Outsourcing-Pharma takes a look back at some of these announcements, as...

O2h to do ‘heavy lifting’ as part of synthetic chemistry collaboration with Cedilla

17-Sep-2019 By Melissa Fassbender

Cedilla Therapeutics and o2h Discovery have announced a multi full-time-equivalent (FTE) expansion to their synthetic chemistry collaboration.

Covance doubles capacity with new R&D center in China

12-Sep-2019 By Vassia Barba

Covance opens a new facility in Shanghai, its biggest in Asia Pacific, to boost its research and development services offering.

Charles River ups microbial solutions offering

12-Sep-2019 By Melissa Fassbender

Charles River has added to its microbial solutions offering with two new products that aim to reduce risk and increase the efficiency of drug testing.